This site is intended for health professionals only

At the heart of general practice since 1960

Read the latest issue online

Gold, incentives and meh

Report this comment to a moderator

Please fill in the form below if you think a comment is unsuitable. Your comments will be sent to our moderator for review.

Report comment to moderator

Required fields.

Headline

Pregabalin and gabapentin set to become controlled drugs

Comment

Useful for a small group of people, but addictive and abusable. In the acute setting and some cases of true neuropathic pain, have some benefits. Like opioids, the problem is they induce euphoria - and persistent pain is a complex phenomenon with low mood being one of the components. So we prescribe a drug which isnt helping the pain, but it temporarily makes patients feel better for a few hours - so of course they will like it. But is it much better than asking them to drinking a few pints to take their minds off things? No - very short term, great - but long term, harm and dependence have potential to rear their heads. Persistent pain doesnt respond well to pharmacology - it needs a psychosocial approach (Pain toolkit is good as a starting point) - this takes time, we dont have much of it, nor resources. So can see why prescribing a short acting euphoriant can be seen initially as success.....until they come back for more wanting higher doses........Same principle as applies to opioid prescribing concerns - and benzos etc....

Posted date

24 Sep 2017

Posted time

5:58pm

required
required
required